A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir

Remdesivir (GS-5734), a viral RNA-dependent RNA polymerase (RdRP) inhibitor that can be used to treat a variety of RNA virus infections, is expected to be an effective treatment for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. On May 1, 2020, The U.S. Food and Drug Adminis...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Eur J Med Chem
Egile Nagusiak: Liang, Chengyuan, Tian, Lei, Liu, Yuzhi, Hui, Nan, Qiao, Guaiping, Li, Han, Shi, Zhenfeng, Tang, Yonghong, Zhang, Dezhu, Xie, Xiaolin, Zhao, Xu
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Elsevier Masson SAS. 2020
Gaiak:
Review Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7834743/
https://ncbi.nlm.nih.gov/pubmed/32563812
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejmech.2020.112527
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak